Health Canada: MDSAP Could Force Some Manufacturers Out With the approaching deadline for those in Canada to comply with the Medical Device Single Audit Program (MDSAP), Health Canada issued a notice ...

DITTA Offers Tips to Tackle MDSAP Issues In a recent comment to the US Food and Drug Administration (FDA), a global medical technology organization comprised of several industry trade associations ...

Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Medical Device Single Audit Programme (MDSAP) (June 25th - June 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The Medical ...

WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (KNE:CA) (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single ...

ATLANTA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc., a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, ...

Alpha Tau Medical Ltd. announced that it has achieved Medical Device Single Audit Program (MDSAP) certification for its manufacturing facility in Jerusalem, which is a key step in ensuring quality, ...

ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to ...

Holger Wagner, Head of Regulatory Affairs at Drägerwerk AG, has spearheaded transformative advancements in global compliance. With more than 17 years of experience, including a couple of years as a ...

MARTINEZ, Calif.--(BUSINESS WIRE)--ExThera Medical Corporation announces it has received simultaneous certification per Medical Device Single Audit Program (MDSAP) and International Organization for ...

TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

JERUSALEM, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...